Form 4: Treace Medical Concepts CEO Buys Shares
Insider Transaction (Form 4)
John T. Treace, Chief Executive Officer, a Director and 10% owner of Treace Medical Concepts, Inc., purchased 55,944 shares of common stock on August 20, 2026.
Summary
- Open-market purchase: acquired 39,944 Common Stock at $4.44 ($177,176) on August 20, 2026; holds 7,388,383 after (Direct).
- Open-market purchase: acquired 5,000 Common Stock at $4.35 ($21,748) on August 21, 2026; holds 7,393,383 after (Direct).
- Open-market purchase: acquired 11,000 Common Stock at $4.34 ($47,731) on August 24, 2026; holds 7,404,383 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $246,654, committing personal capital to the stock.
Insider Transactions
John T. Treace — Director, Officer (Chief Executive Officer), 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-20 | Open-market purchase | Common Stock | 39,944 | $4 | $177.2K | 7,388,383 |
| 2026-08-21 | Open-market purchase | Common Stock | 5,000 | $4 | $21.7K | 7,393,383 |
| 2026-08-24 | Open-market purchase | Common Stock | 11,000 | $4 | $47.7K | 7,404,383 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-20 | Open-market purchase (39,944 shares) |
| 2026-08-21 | Open-market purchase (5,000 shares) |
| 2026-08-24 | Open-market purchase (11,000 shares) |
Keywords
insider transaction, Form 4, TMCI, TREACE MEDICAL CONCEPTS, INC., bullish, John T. Treace
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.